Home/Filings/4/0001055726-25-000033
4//SEC Filing

Sumner Michael John 4

Accession 0001055726-25-000033

CIK 0001055726other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 4:57 PM ET

Size

8.1 KB

Accession

0001055726-25-000033

Insider Transaction Report

Form 4
Period: 2025-05-20
Sumner Michael John
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Unit

    2025-05-20+28,35028,350 total
    Common Stock (28,350 underlying)
  • Award

    Common Stock Option

    2025-05-20+35,10035,100 total
    Exercise: $2.13Exp: 2035-05-20Common Stock (35,100 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units is as follows: 9,450 shares will vest on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
  • [F2]The vesting schedule for the 31,500 options is as follows: 17,550 shares will vest on May 20, 2027 and 17,550 shares will vest on May 20, 2028.

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001936799

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:57 PM ET
Size
8.1 KB